The pharmaceutical research industry’s productivity is declining and the cost is rising, a dangerous combination that is the force behind changes in how drug companies do research. India has a favorable clinical research environment and offers the following advantages:

• Population of 1 Billion
• Diverse treatment naïve patient population
• Low per patient trial cost
• Rapid patient recruitment
• English speaking research professionals